| HOME >> MEDICINE >> TECHNOLOGY |
Peregrine Opens Subsidiary in China 52
InterMune Completes Production Milestone 53
Arrow Expands Hepatitis C Pipeline 53
Roche Wins Japanese Approval for Combination Therapy 53
Schering-Plough Bags European Commission Approval for
Combination Therapy 53
Abbott Bags FDA Approval for Screening Test 53
Abbott Bags Canadian Approval for Viral Load Tests 54
Phynova Bags FDA Approval for IND Application 54
Worldwide Biotech Bags Chinese FDA Approval for HCV Diagnostic
Tibotec Applies to European Regulator to Initiate Phase I Trials 54
Roche Submits Application for Novel Hepatitis C to with FDA 55
Anadys Discontinues ANA975 55
Cerus Bags NIH Funding for HCV Vaccine Program 55
Human Genome Gets Encouraging Interim Results with Albuferon 55
Intarcia Releases Study Results of Omega Interferon 55
Nautilus Biotech Commences Phase I Study for Belerofon® 56
Migenix Announces Phase II Proof-of-Concept Study Results of
Celgosivir 56
Pharmasset Begins Multiple Dose-Escalating Study of R7128 57
Transgene Commences Phase I Trial of TG4040 57
Debiopharm Releases Phase Ib Results of Debio 025 57
Nabi Biopharmaceuticals Starts Proof-Of- Concept Trial for
Civacir 57
Peregrine Announces Positive Results for Bavituximab 58
7. MAJOR PLAYERS 59
Abbott Diagnostics (USA) 59
Achillion Pharmaceuticals, Inc. (USA) 59
Anadys Pharmaceuticals, Inc. (USA) 59
Boehringer Ingelheim GmbH (Germany) 59
Bristol-Myers Squibb Company (USA) 59
F. Hoffmann-La Roche Ltd. (Switzerland) 60
GlaxoSmithKline plc (UK) 60
Hayashibara Biochemical Labs, Inc. (Japan) 60
HemispheRx Biopharma, Inc. (USA) 60
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |